Sectors
CLB
Core Laboratories N.V.
12.14
1 x 12.12
1 x 12.17
bid
ask
+
0.73
6.40%
11:14 AM
timesize
| Ytd | -24.27% | |
| 1y | 3.15% |
11.28
day range
12.21
9.72
52 week range
20.36
| Open | 11.62 | Prev Close | 11.41 | Low | 11.28 | High | 12.21 | Mkt Cap | 525.96M |
| Vol | 335.47K | Avg Vol | 807.04K | EPS | 0.68 | P/E | 16.78 | Forward P/E | 17.18 |
| Beta | 1.00 | Short Ratio | 23.15 | Inst. Own | 112.62% | Dividend | 0.04 | Div Yield | 0.35 |
| Ex Div Date | 11-04 | Earning | 07-29 | 50-d Avg | 12.48 | 200-d Avg | 15.37 | 1yr Est | 19.33 |
| Income Statement | |||
| Total Revenue | 121.80M | ||
| Revenues (USD) | 121.80M | ||
| Cost of Revenue | 102.07M | ||
| Gross Profit | 19.72M | ||
| Operating Expenses | 17.84M | ||
| Selling, General and Administrative Expense | 14.72M | ||
| Operating Income | 1.89M | ||
| Interest Expense | 2.89M | ||
| Income Tax Expense | -251.00K | ||
| Net Income | -789.00K | ||
| Net Income Common Stock | -789.00K | ||
| Net Income Common Stock (USD) | -789.00K | ||
| Consolidated Income | -753.00K | ||
| Net Income to Non-Controlling Interests | 36.00K | ||
| Earnings per Basic Share | -0.02 | ||
| Earnings per Basic Share (USD) | -0.02 | ||
| Earnings per Diluted Share | -0.02 | ||
| Dividends per Basic Common Share | 0.01 | ||
| Earning Before Interest & Taxes (EBIT) | 1.85M | ||
| Earning Before Interest & Taxes (USD) | 1.85M | ||
| Weighted Average Shares | 46.07M | ||
| Weighted Average Shares Diluted | 46.07M | ||
| Balance Sheet | |||
| Cash and Equivalents | 22.82M | ||
| Cash and Equivalents (USD) | 22.82M | ||
| Trade and Non-Trade Receivables | 108.28M | ||
| Current Assets | 214.37M | ||
| Property, Plant & Equipment Net | 154.69M | ||
| Total Assets | 587.73M | ||
| Debt Current | 12.10M | ||
| Total Debt | 167.84M | ||
| Current Liabilities | 104.73M | ||
| Debt Non-Current | 155.75M | ||
| Total Liabilities | 312.58M | ||
| Accumulated Retained Earnings (Deficit) | 171.41M | ||
| Accumulated Other Comprehensive Income | -5.75M | ||
| Shareholders Equity | 268.89M | ||
| Shareholders Equity (USD) | 268.89M | ||
| Assets Non-Current | 373.36M | ||
| Total Debt (USD) | 167.84M | ||
| Deferred Revenue | 4.71M | ||
| Goodwill and Intangible Assets | 112.69M | ||
| Inventory | 57.78M | ||
| Liabilities Non-Current | 207.85M | ||
| Trade and Non-Trade Payables | 39.98M | ||
| Tax Assets | 78.21M | ||
| Tax Liabilities | 16.35M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 3.76M | ||
| Net Cash Flow from Financing | -457.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 117.00K | ||
| Capital Expenditure | -3.39M | ||
| Issuance (Purchase) of Equity Shares | -4.00M | ||
| Issuance (Repayment) of Debt Securities | 4.00M | ||
| Payment of Dividends & Other Cash Distributions | -460.00K | ||
| Net Cash Flow from Investing | -3.39M | ||
| Net Cash Flow from Operations | 3.97M | ||
| Share Based Compensation | 5.03M | ||